Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001700205-24-000004
Filing Date
2024-11-14
Accepted
2024-11-14 12:33:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12962
2 brtx_ex1.pdf EX-1 48004
  Complete submission text file 0001700205-24-000004.txt   80964
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Subject) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-86699 | Film No.: 241459452
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)

Mailing Address 101 ARCH ST 20TH FLOOR BOSTON MA 02110
Business Address 101 ARCH ST 20TH FLOOR BOSTON MA 02110 617-532-6405
Auctus Fund Management LLC (Filed by) CIK: 0001700205 (see all company filings)

EIN.: 263675912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A